Clinical Analysis of 21 Patients with Thrombotic Thrombocytopenic Purpura

王荷花,陈惠珍,童秀珍,李娟,张国材,彭爱华,罗绍凯
DOI: https://doi.org/10.16766/j.cnki.issn.1674-4152.2010.10.027
2010-01-01
Abstract:Objective To summarize the clinical features and treatment of thrombotic thrombocytopenic purpura(TTP).Methods The clinical and laboratory data of 21 cases with TTP were reviewed retrospectively.Results Median age of the 21 patients was 38 years.As the initial clinical presentation,the classic pentad of thrombocytopenia,microangiopathic hemolytic anemia(MAHA),fluctuating neurological signs,renal dysfunction,and fever was 13 episodes,12 episodes,16 episodes,1 episode and 7 episodes.The pentad of clinical and/or laboratory abnormalities presented at diagnosis in 100%,100%,95%,67% and 67% of cases,respectively.Ninty-five percent of TTP patients presented with the triad of thrombocytopenia,MAHA,and neurologic dysfunction,and only 57% with the classic pentad signs.16 patients after diagnosis received either plasma exchange(PE) or plasma infusion(PI).With follow-up(median,42 months;range 9 to 118 months),eight patients in PE group were all cured.Of the 8 patients treated with PI,four patients were cured;two relapsed;two deteriorated and died.The efficacy of PE had significantly better outcome than that of PI(cure rate:100% versus 50%,P=0.038).Conclusion The most prominent clinical abnormalities of TTP at presentation are the triad of thrombocytopenia,MAHA and fluctuating neurological signs.PE is more efficacious than PI.If reduced level of consciousness has been identified,PE should be instituted as soon as practicable.
What problem does this paper attempt to address?